On November 18, 2016, Judge Mary Wiss appointed Michael Brady Lynch, Lead Trial attorney and founder of The Michael Brady Lynch Firm to serve on the Plaintiff’s Executive Committee (PEC) in Pradaxa litigation JCCP 4863.

Attorneys across the country have continually asked Attorney Michael Brady Lynch to step into leadership positions for many litigations. Lynch currently serves on the Plaintiff’s Steering Committee (PSC) in Viagra litigation MDL #2591. Also, he served on a previous PSC in Pradaxa MDL #2385. In this case, Boehringer went on to settle Pradaxa claims for over $650 million. Lynch is dedicated to bringing the same determination for justice to this new Pradaxa litigation.

On the PEC, Attorney Michael Brady Lynch will assist Co-Lead Counsel in important litigation decisions. Lynch will also help organize and execute pretrial and trial activities. Lynch takes this position very seriously. His firm has led the second wave of Pradaxa filings to help additional victims unable to file before the original settlement date.

Pradaxa is a dangerous drug affecting thousands of people. If you have experienced internal bleeding, hemorrhaging, stroke, heart attack or have lost a loved one after Pradaxa use, you may be eligible for compensation to offset your financial, physical and emotional burdens. You deserve the best representation to file your claim. Michael Brady Lynch and his team of knowledgeable attorneys are the best Pradaxa attorneys in the country. They know how to go up against huge pharmaceutical giants like Boehringer and come out victorious.

Contact us today to set up a free consultation during which we will listen to you and discuss your legal rights and options. If you choose us to represent you, we will work with you on a contingency fee basis; this means you pay nothing until we have secured compensation for you, either through a jury verdict or settlement.

Learn more about Pradaxa.